Patient Cost-Sharing and Healthcare Spending Growth
Bibliographic Data
| ID | 4030345 |
|---|---|
| Authors | Katherine Baicker (0000-0001-5960-3058, Professor of Health Economics in the Department of Health Policy and Management at the Harvard School of Public Health, Boston, Massachusetts.), Dana P Goldman (0000-0001-8498-6396, RAND Corporation), Dana Goldman (Norman Topping Chair in Medicine and Public Policy at the University of Southern California, Los Angeles, California and a senior economist at the RAND Corporation, Santa Monica, California.) |
| Year | 2011 |
| Volume | 25 |
| Issue | 2 |
| Pages | 47-68 |
| Publication date | 2011-05-01 |
| Peer Reviewed | Yes |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | The Journal of Economic Perspectives (JOURNAL) |
| Journal identifiers | ISSN: 0895-3309 • E-ISSN: 1944-7965 |
| Publisher | American Economic Association (PUBLISHER • US) |
| DOI | 10.1257/jep.25.2.47 |
| PMID | 21595325 |
| OpenAlex | W2165554168 |
| Language | EN |
| Citations received | 13 |
| References cited | 41 |
In this paper, we explore the role patient incentives play in slowing healthcare spending growth. Evidence suggests that while patients do indeed respond to financial incentives, cost-sharing does not uniformly improve value; rather, cost-sharing provisions must be deliberately structured and targeted to reduce care of low marginal value. Other mechanisms may be helpful in targeting particular populations or types of utilization. The spillover effects between privately insured and publicly insured populations as well as market imperfections suggest a potential role for public policy in promoting insurance design that slows spending growth while increasing the health that each dollar buys
Actuarial science · Business · Cost sharing · Economic growth · Economics · Health care · Incentive · Liberian dollar · Microeconomics · Monetary economics · Public economics · Public spending · Spillover effect · Global Health Care Issues · Healthcare Policy and Management · Healthcare Systems and Reforms · Medicine · Finance
Global health 2035
Medicare Must Provide Additional Cost and Access Information to Enhance Decision Making Around Trade Offs Between Medicare Advantage and Medigap
The Impact of Cost-Containment Schemes on Outpatient Services for Schoolchildren with Refractive Errors in Taiwan—A Population-Based Study
Rethinking Health Insurance Design
Understanding patient and physician responses to various cost-sharing programs for prescription drugs in South Korea
Expenditure response to patient cost-sharing
Revisiting equity in healthcare spending through capability-approach
Perceived affordability of health insurance and medical financial burdens five years in to Massachusetts health reform
In the Shadow of a Giant
A Chinese conundrum
Chronic Health Outcomes and Prescription Drug Copayments in Medicaid
Patient cost-sharing, mental health care and inequalities
Effects of reduced cost-sharing on children's health
Adverse Events Associated With Prescription Drug Cost-Sharing Among Poor and Elderly Persons
The Implications of Regional Variations in Medicare Spending. Part 2
Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
Can patient self-management help explain the SES health gradient?
Prescription Drug Cost Sharing
The Implications of Regional Variations in Medicare Spending. Part 1
The Benefits of Risk Factor Prevention in Americans Aged 51 Years and Older
The Effect of Office Visit Copayments on Utilization in a Health Maintenance Organization
| Unique citing works | 13 |
|---|---|
| Citations per year | 1 |
| Citation span | 2013 - 2025 (13) |
| Citation velocity | recent |
| Highly cited | No |
| Citation types | Neutral: 13 |